肾下腹主动脉瘤修复术后30天再入院:指征、危险因素与结局
基于Premier医疗数据库2009至2015年的回顾性分析,共纳入33,332例肾下腹主动脉瘤修复术(EVAR 82.5%,OAR 17.5%),30天再入院率为8.1%,OAR高于EVAR(12.9% vs 7.1%,P<.001)。多因素调整后OAR与再入院独立相关(aOR 1.11,95%CI 1.0-1.2,P=.04),再入院患者院内死亡率为3.6%,中位再住院费用7757美元。
要点
- 肾下腹主动脉瘤修复术后30天再入院率为8.1%,开放修复高于腔内修复。
- 再入院最常见诊断依次为感染并发症、呼吸并发症和心脏并发症。
- 女性、急诊/紧急手术、多种合并症及非家庭出院是再入院的危险因素。
核心结论
- 约8.1%的肾下腹主动脉瘤修复患者30天内再入院,开放修复再入院风险高于腔内修复。
- 许多再入院与索引手术无关或由不可改变/出院时不可识别的因素导致,应聚焦出院计划和高危患者出院后协调。
研究设计与样本
- 回顾性分析Premier医疗数据库2009至2015年数据,共识别33,332例肾下腹主动脉瘤修复术。
- 其中腔内修复27,483例(82.5%),开放修复5,849例(17.5%)。
- 采用多因素logistic模型评估30天再入院与患者及医院因素的关联。
主要发现
- 总体30天再入院率为8.1%,开放修复为12.9%,腔内修复为7.1%(P<.001)。
- 再入院最常见具体诊断为感染并发症(16.1%),其次为呼吸并发症(11.8%)和心脏并发症(11.3%)。
- 多因素调整后,开放修复与30天再入院相关(aOR 1.11,95%CI 1.0-1.2,P=.04)。
- 再入院患者总体院内死亡率为3.6%,中位再住院费用为7757美元。
关键数值与推荐
- 再入院危险因素包括女性、急诊和紧急手术、血脂异常、充血性心力衰竭、短暂性脑缺血发作史、既往心脏手术、慢性阻塞性肺疾病、哮喘、慢性肾脏病、外周血管疾病、恶性肿瘤病史。
- 索引住院期间出血/休克/出血事件及非家庭出院也是再入院危险因素。
临床怎么用
- 对开放修复、女性、急诊手术及合并多种 comorbidity 的高危患者应加强出院计划。
- 优化出院目的地决策和出院后照护协调,可能减少可避免的再入院。
局限性
- 回顾性数据库分析,可能存在编码偏倚和未测量混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Reducing readmissions is an important target for improving patient care and enhancing health care quality and cost-effectiveness. The aim of this study was to assess rates, risk factors, and indications of 30-day readmission after open aortic repair (OAR) and endovascular aneurysm repair (EVAR) of infrarenal abdominal aortic aneurysms (AAAs). METHODS: A retrospective analysis of the Premier Healthcare Database from 2009 to 2015 was performed. Indications for readmission after the index procedure, risk factors, and outcomes of the index admission and rehospitalization were evaluated. Multivariate logistic models were used to assess the association between 30-day readmission and different patient and hospital factors. RESULTS: A total of 33,332 AAA repair procedures were identified: 27,483 (82.5%) EVAR and 5849 (17.5%) OAR. The overall rate of 30-day readmission was 8.1%, and it was greater after OAR (12.9% vs 7.1% in EVAR; P < .001). In general, the most common specific readmission diagnoses were infectious complications (16.1%), followed by respiratory and cardiac complications (11.8% and 11.3%, respectively). After multivariate adjustment, OAR was associated with higher 30-day readmission compared with EVAR (adjusted odds ratio, 1.11; 95% confidence interval, 1.0-1.2; P = .04). Other risk factors of 30-day readmission included female gender, emergency and urgent procedures, certain patient comorbidities (dyslipidemia, congestive heart failure, history of transient ischemic attack, previous cardiac surgery, chronic obstructive pulmonary disease, asthma, chronic kidney disease, peripheral vascular disease, and history of malignant disease), and hemorrhage/shock/bleeding occurring during the index admission as well as nonhome discharge. Readmitted patients had an overall in-hospital mortality of 3.6% and paid a median rehospitalization cost of $7757. CONCLUSIONS: Our study shows that around 8.1% of patients undergoing infrarenal AAA repair were readmitted within 30 days. Because many readmissions are unrelated to the index procedure or caused by factors that are nonmodifiable or nonidentifiable at discharge, efforts should focus on discharge planning and improving the decision process regarding discharge destination as well as postdischarge coordination of care for high-risk patients.
引用
- Dakour Aridi HN, Locham S, Nejim B, et al. Indications, risk factors, and outcomes of 30-day readmission after infrarenal abdominal aneurysm repair. J Vasc Surg. 2017. PMID: 28947230. doi:10.1016/j.jvs.2017.07.106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。